Causes of Anemia

Understanding the Causes of Anemia Anemia occurs when a person has an insufficient number of red blood cells or hemoglobin to carry oxygen effectively to body tissues. Understanding why anemia develops—its etiology—requires examining three fundamental mechanisms: blood loss, impaired red blood cell production, and increased red blood cell destruction. Additionally, changes in blood volume can dilute the concentration of red blood cells. Let's explore each of these causes in detail. Blood Loss Blood loss causes anemia when iron-containing hemoglobin leaves the body faster than new red blood cells can be produced to replace it. This can occur gradually (chronic blood loss) or suddenly (acute blood loss). Chronic blood loss is particularly common in women of reproductive age. Menstrual bleeding, especially when periods are abnormally heavy (menorrhagia) or when fibroids are present, represents a significant chronic source of iron loss. In fact, heavy menstrual bleeding is one of the most common causes of iron-deficiency anemia worldwide in women. The gastrointestinal tract is another frequent source of chronic bleeding. Peptic ulcers, esophageal varices (enlarged veins in the esophagus), angiodysplasia (abnormal blood vessel formations), and gastrointestinal malignancies can all cause slow, persistent blood loss that accumulates over time. Acute blood loss occurs suddenly following trauma, major surgery, or severe injury. While the body can temporarily compensate for a single large blood loss, repeated losses compound the problem. Iatrogenic blood loss—bleeding caused by medical treatment—often goes unrecognized. Repeated phlebotomy (drawing blood for laboratory tests) or blood donation, while usually well-tolerated in healthy individuals, can deplete iron stores over time, particularly in frequent donors. Parasitic infections also deserve mention, particularly in tropical and developing regions. Hookworm and whipworm infect the intestinal tract and feed on blood, causing chronic ongoing blood loss that can lead to severe iron-deficiency anemia. Impaired Red Blood Cell Production The bone marrow normally produces approximately 200 billion red blood cells daily to maintain steady-state levels. When this production falls behind, anemia develops. Problems can arise from insufficient nutrients, genetic defects, or bone marrow failure. Iron-Deficiency Anemia Iron is absolutely essential for hemoglobin synthesis. Without adequate iron, the body cannot produce hemoglobin efficiently, leading to iron-deficiency anemia. This develops when dietary iron intake is insufficient, iron absorption is impaired (such as after gastric surgery or in celiac disease), or iron losses exceed intake (as discussed in the blood loss section above). Iron deficiency typically develops gradually, first depleting iron stores, then affecting hemoglobin production. The resulting red blood cells are small (microcytic) and pale (hypochromic). Folate and Vitamin B12 Deficiency Anemia Both folate and vitamin B12 are essential cofactors for DNA synthesis. When either is deficient, the bone marrow cannot properly synthesize DNA, which impairs the normal cell division required to produce new red blood cells. Folate deficiency results from inadequate dietary intake (green leafy vegetables are the primary source), malabsorption, or increased requirements during pregnancy. Because folate is water-soluble and not stored long-term in the body, deficiency develops relatively quickly. Folate deficiency produces macrocytic red blood cells (larger than normal) that appear immature under the microscope. Vitamin B12 deficiency also causes macrocytic anemia but adds a critical additional problem: neurological damage. B12 is essential for myelin formation, so deficiency can cause peripheral neuropathy, weakness, and even cognitive changes. Unlike folate, B12 is stored in the liver for years, so deficiency develops slowly. The most common cause of B12 deficiency is pernicious anemia, which results from lack of intrinsic factor—a protein the stomach produces that is necessary for B12 absorption. Pernicious anemia is an autoimmune condition where the immune system destroys the cells that produce intrinsic factor. Another important cause is gastrointestinal surgery (such as gastrectomy or bariatric surgery) that removes the portion of the stomach producing intrinsic factor or reduces the ability to absorb B12. Thalassemia and Other Genetic Disorders Genetic defects in hemoglobin or red blood cell production cause congenital (inherited) anemias. Thalassemia results from defective globin chain synthesis. Alpha-thalassemia involves mutations affecting alpha-globin genes, while beta-thalassemia affects beta-globin genes. Both cause microcytic anemia, but the severity depends on the number of affected genes. Thalassemia is particularly common in Mediterranean, Middle Eastern, and Southeast Asian populations. Sickle cell anemia and other hemoglobinopathies involve mutations that produce abnormal hemoglobin proteins. In sickle cell disease, hemoglobin polymerizes under low oxygen conditions, distorting red blood cells into a characteristic crescent or sickle shape. These abnormal cells break down prematurely (hemolysis), leading to anemia. Bone Marrow Failure Syndromes Sometimes the bone marrow itself fails to produce adequate red blood cells, despite having adequate nutrients and appropriate hormonal signals. Aplastic anemia occurs when bone marrow production fails entirely, resulting in low numbers of red blood cells, white blood cells, and platelets. This can result from autoimmune destruction of bone marrow stem cells, toxic drug exposure, severe infections, or radiation. Pure red cell aplasia is a more selective failure affecting only red blood cell production, leaving white blood cells and platelets relatively normal. Myelophthisic anemia develops when the bone marrow is physically replaced or infiltrated by tumors, fibrosis, or granulomas (collections of immune cells), crowding out the normal blood-producing cells. Myelodysplastic syndromes involve defective blood cell production (dysplasia) with ineffective erythropoiesis—the bone marrow produces immature or defective red blood cells that die before reaching mature function. This leads to anemia despite increased marrow activity. Increased Red Blood Cell Destruction (Hemolysis) Hemolysis—the premature breakdown of red blood cells—reduces the lifespan of red blood cells from the normal 120 days to hours or days. When hemolysis is rapid enough that the bone marrow cannot compensate with increased production, anemia results. Intrinsic (Hereditary) Hemolytic Disorders Some red blood cells have inherent structural or biochemical defects that make them fragile and prone to destruction. Hereditary spherocytosis and hereditary elliptocytosis involve defects in red blood cell membrane proteins that normally maintain cell shape and flexibility. Affected red blood cells become rigid and spherical (or elliptical), making them prone to being trapped and destroyed in the spleen. Enzyme deficiencies in red blood cells reduce their ability to protect against oxidative damage. These include: Pyruvate kinase deficiency reduces energy (ATP) production, weakening the red blood cell Glucose-6-phosphate dehydrogenase (G6PD) deficiency impairs antioxidant defenses, particularly affecting cells in high-stress conditions (infections, certain drugs, fava beans) Hexokinase and glutathione synthetase deficiencies similarly impair the red blood cell's ability to handle oxidative stress All of these conditions cause hemolysis by rendering red blood cells vulnerable to mechanical stress or oxidative damage. Extrinsic (Acquired) Hemolytic Disorders These conditions involve external factors attacking otherwise healthy red blood cells. Warm autoimmune hemolytic anemia occurs when the immune system produces IgG antibodies that bind to red blood cells, marking them for destruction by the spleen. This can be idiopathic (no clear cause), drug-induced (certain medications can trigger autoimmunity against red blood cells), or secondary to systemic lupus erythematosus, chronic lymphocytic leukemia, or other conditions. Cold agglutinin disease involves IgM antibodies that bind to red blood cells only at cold temperatures. These antibodies cause red blood cells to clump together (agglutinate) in cold extremities and are then destroyed. This condition often follows infections like Mycoplasma or infectious mononucleosis. Hemolytic disease of the newborn, classically Rh disease, develops when maternal antibodies cross the placenta and attack fetal red blood cells. This occurs when an Rh-negative mother (lacking the Rh antigen) becomes sensitized to Rh-positive fetal blood (which carries the antigen) and produces IgG antibodies against it. Modern prevention with Rh immunoglobulin has made this rare in developed countries. Mechanical hemolysis occurs from direct physical trauma to red blood cells. Prosthetic heart valves can mechanically damage red blood cells as they pass through, and extracorporeal circulation (such as during heart-lung bypass during surgery) can destroy red blood cells through shear stress. Microangiopathic hemolytic anemias involve mechanical fragmentation of red blood cells as they try to navigate through partially blocked small blood vessels. Thrombotic thrombocytopenic purpura (TTP) and disseminated intravascular coagulation (DIC) both cause fibrin strands to form in vessels, which shred red blood cells like razor wire. Infections can directly cause hemolysis. Malaria parasitizes red blood cells and causes their rupture; some strains of Trypanosoma (which cause sleeping sickness) also directly hemolyze cells. Various other infections can trigger immune-mediated hemolysis. Fluid Overload (Dilutional Anemia) Anemia doesn't always mean too few red blood cells—it can also result from too much plasma (the fluid component of blood) diluting the concentration of hemoglobin. Hypervolemia (excessive blood volume) can result from excessive sodium or fluid intake, impaired fluid excretion (in kidney or heart disease), or shifts of fluid from tissues into the bloodstream. When plasma volume increases without a proportional increase in red blood cell number, hemoglobin concentration falls, creating a dilutional anemia. Physiologic dilutional anemia is a normal occurrence during pregnancy. During the second trimester, plasma volume expands rapidly (up to 50% increase) to meet the needs of pregnancy, but red blood cell mass increases much more slowly. This results in a normal, physiologic dilution of hemoglobin that requires no treatment and resolves after delivery. <extrainfo> Global Nutritional and Socio-Economic Contributors While the mechanisms above explain how anemia develops, global health patterns show clear socioeconomic patterns in who develops anemia. Nutritional deficiency drives much of the global burden of anemia. Iron, folate, and vitamin B12 deficiency together account for a substantial proportion of anemia worldwide. In low-income populations with limited food diversity and poor access to nutrient-rich foods—particularly animal products (the best source of heme iron and B12) and fresh vegetables (sources of folate)—nutritional anemia is endemic. Pregnancy dramatically increases the nutritional demands for iron. A pregnant woman needs approximately 27 mg of iron daily (compared to 8-18 mg in non-pregnant women). In resource-poor settings where dietary iron intake is already marginal, pregnancy commonly precipitates iron-deficiency anemia and remains a leading cause of anemia in reproductive-age women worldwide. Chronic infections compound nutritional anemia. Malaria is endemic in tropical regions and causes both direct hemolysis and impaired erythropoiesis. Parasitic infections like hookworm and whipworm cause both chronic blood loss and nutritional depletion. These infections are concentrated in areas with poor sanitation and limited healthcare access—the same areas with marginal nutrition. Poverty and limited healthcare access create a vicious cycle: poor nutrition, high parasitic burden, limited access to preventive measures and treatment, and reduced ability to address complications—all converging to create high rates of anemia in vulnerable populations, particularly children and women of reproductive age. </extrainfo>